Shubham Pant: Targeted Therapies for Pancreatic Cancer – Hope on the Horizon
Shubham Pant, Professor of Gastrointestinal Medical Oncology and Investigational Cancer Therapeutics at MD Anderson Cancer Center, shared on LinkedIn:
“Grateful to have been invited by the fellows at the University of Oklahoma for Hematology-Oncology Grand Rounds.
My talk, “Targeted Therapies for Pancreatic Cancer: Hope on the Horizon,” focused on why I believe we are entering a new era for this disease!!
Shared some of the promising that are truly reshaping the landscape of pancreatic cancer: KRAS, MTAP, and the target that we see more studies on now in Pancreatic Cancer: Claudin18.2
The best part? Engaging with the fellows and faculty about the Next in Pancreatic Cancer. The future, as they say, is bright!”
More Posts Featuring Pancreatic Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023